Serum Pepsinogen I: An Early Marker of Pernicious Anemia in Patients with Type 1 Diabetes | Zendy

Núria Alonso | Zendy; María Luisa Granada | Zendy; Isabel Salinas | Zendy; Ana M. Lucas | Zendy; Jordi L. Reverter | Zendy; Jordi Juncà | Zendy; Albert Oriol | Zendy; Ana Sanmartí | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Pepsinogen I: An Early Marker of Pernicious Anemia in Patients with Type 1 Diabetes

Author(s) -

Núria Alonso,

María Luisa Granada,

Isabel Salinas,

Ana M. Lucas,

Jordi L. Reverter,

Jordi Juncà,

Albert Oriol,

Ana Sanmartí

Publication year - 2005

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-0580

Subject(s) - medicine , gastroenterology , pepsin , pernicious anemia , achlorhydria , gastrin , autoimmune gastritis , pernicious anaemia , population , esophagogastroduodenoscopy , diabetes mellitus , endocrinology , anemia , gastritis , stomach , endoscopy , environmental health , biochemistry , chemistry , secretion , enzyme

Pernicious anemia (PA) is an autoimmune organ disease much more common in type 1 diabetic patients (DM1) than in nondiabetic subjects, but it is clinically silent until its end stage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research